期刊文献+

经抽吸导管早期应用维拉帕米对急性心肌梗死再灌注无复流的疗效观察 被引量:2

Beneficial effect of early administration of intracoronary verapamil via thrombus-aspirating device in patients with acute myocardial infarction with no-reflow
原文传递
导出
摘要 目的探讨经抽吸导管冠状动脉内早期给予维拉帕米治疗急性ST段抬高心肌梗死(AMI)患者直接经皮冠状动脉介入治疗(P-PCI)术中无复流现象的疗效。方法 168例AMI患者进行直接PCI术,先行抽吸导管抽吸血栓后,随机分成两组,A组(n=86):经抽吸导管向靶病变远端给予维拉帕米100~200μg/次,总量不超过600μg;B组(n=82):支架植入发生无复流现象后再通过指引导管向冠状动脉内给予维拉帕米100~200μg/次,总量不超过600μg。造影评价给药前后冠状动脉血流心肌梗死溶栓试验(TIMI)分级和TI-MI心肌组织灌注分级(TMPG),评价术后1 h心电图ST段下降情况。结果术后A组TIMI 3级血流比例明显高于B组(91.86%vs.80.49%,P<0.05);术后A组TMPG 3级比例明显高于B组(88.37%vs.75.61%,P<0.05);A组心电图ST段迅速下降比例明显高于B组(80.23%vs.65.85%,P<0.05)。结论早期经抽吸导管向靶病变远端给予维拉帕米较传统方法进一步减少了AMI患者P-PCI术中无复流现象的发生。 Objective To evaluate the effects of early administration of intracoronary verapamil via thrombus-aspirating device on no-reflow phenomenon during primary percutaneous coronary intervention(P-PCI) in patients with acute ST elevation myocardial infarction.Methods Consecutive 168 patients with ST elevation acute myocardial infarction treated with P-PCI were enrolled,thrombotic clot was aspired before stent was implanted via thrombus-aspirating device first.Patients were divided into two groups randomly.Group A(n=86):the first single bolus of verapamil of 100 to 200 μg was administered to distal end of target lession via thrombus-aspirating device,the total amount was less than 600 μg.Group B(n=82):the first single bolus of intracoronary verapamil of 100 to 200 μg was administered via guiding catheter after no-flow phenomenon,the total amount was less than 600 μg.Thrombolysis in myocardial infarction(TIMI)flow grade,TIMI myocardial perfusion grade(TMPG)before and after administration and resolution of ST segment elevation an hour after P-PCI were assessed.Results After PCI,compared with group B,group A showed significantly higher TIMI 3 flow degree:91.86% vs.80.49%,P〈0.05;TMPG 3 was found to have higher rate in group A:88.37% vs.75.61%,P〈0.05;group A showed significantly higher rapid resolution of ST segment elevation rate:80.23% vs.65.85%,P〈0.05.Conclusions Compared with conventional process,early administration of verapamil to distal end of target lession via thrombus-aspirating device could decrease the no-flow phenomenon during P-PCI in patients with acute ST elevation myocardial infarction.
出处 《中华临床医师杂志(电子版)》 CAS 2012年第5期28-31,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 心肌梗死 放射摄影术 介入性 维拉帕米 无复流现象 Myocardial infarction Radiography,interventional Verapamil No-reflow phenomenon
  • 相关文献

参考文献15

  • 1Morishima I,Sone T,Okumura K,et al.Angiographic no-reflow phe-nomenon as a predictor of adverse long-term outcome in patients trea-ted with percutaneous transluminal coronary angioplasty for first acutemyocardial infarction.J Am Coll Cardiol,2000,36:1202-1209.
  • 2付强,黄宜杰,吴强,王临光,王海波,路雯,蒋树中,王彦炯.维拉帕米对急性心肌梗死再灌注无再流的干预[J].中华急诊医学杂志,2008,17(7):754-756. 被引量:1
  • 3高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:4989
  • 4杨军,骆秉铨.冠状动脉介入术后心肌无复流的评估及处理[J].中华临床医师杂志(电子版),2009,3(7):18-21. 被引量:14
  • 5Gibson CM,Cannon CP,Muphy SA,et al.Relationship of TIMI myo-cardial perfusion grade to mortality after administration of thrombolyticdrugs.Circulation,2000,101:125-130.
  • 6Tomaszuk-Kazberuk A,Korecki J,Kochman W,et al.Rapid resolutionof ST segment elevation predicts recovery of left myocardial contractionin patients with acute myocardial infarction treated with percutaneouscoronary angioplasty.Przegl Lek,2002,59:638-641.
  • 7Isaaz K,Robin C,Cerisier A,et al.A new approach of primary angio-plasty for for ST-elevation acute myocardial infarction based on mini-malist immediate mechanical intervention.Coron Artery Dis,2006,17:261-269.
  • 8Porto I,Ashar V,Mitchell AR.Pharmacological management of no re-flow during percutaneous coronary intervention.Curr Vasc Phamacol,2006,4:95-100.
  • 9Brosh D,Assali AR,Mager A,et al.Effect of no-flow during primarypercutaneous coronary intervention for acute myocardial infarction onsix-month mortality.Am J Cardiol,2007,99:442-445.
  • 10Movahed MR,Butman SM.The pathogenesis and treatment of no-flowoccurring during percutaneous coronary intervention.Cardiovasc Re-vase Med,2008,9:56-61.

二级参考文献27

  • 1王勇,刘晓飞,李宪伦,曾玉杰,石兵,彭文华,施乐,柯元南.急诊经皮冠状动脉介入治疗急性心肌梗死死亡因素分析[J].中华急诊医学杂志,2006,15(10):876-878. 被引量:19
  • 2李善春,杨军,方毅民,林乐军,徐志英.川芎嗪对急性心肌梗死急诊冠状动脉介入治疗后“心肌无复流”的影响[J].中华核医学杂志,2006,26(6):366-369. 被引量:10
  • 3Isaaz K, Robin C, Cerisier A,et al.A new approach of primary angioplasty for ST-elevation acute myocardial infarction based on minimalist immediate mechanical intervention [J]. Comn Artery Dis,2006,17(3) : 261-269.
  • 4Porto I, Ashar V, Mitchell AR. Pharmacological management of no reflow during percutaneous coronary intervention[J]. Curt Vasc Pharmacol,2006,4(2) :95-100.
  • 5Lee CH, Wong HB, Tan HC, et al. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infaretien-insights from a 1328 patient registry[J]. J Interv Cardiol,2005,18(4):261-266.
  • 6Villanueva FS. Myocardial contrast echocardiography in acute myocardial infarction[J]. Am J Cardiol,2002, 90(10A):38-47.
  • 7Ito H, I Wakura K. Assessing the relation between coronary reflow and myocardial reflow[ J]. Am J Cardiol, 1998,12A: 8-12.
  • 8Nakamura S, Takehana K, Sugiura T, et al. Quantitative estimation of myocardial salvage after primary percutaneous transluminal coronary angioplasty in patients with angiographic no reflow [ J ]. Eur J Nucl Med Mol Imaging,2003,30(3) :383-389.
  • 9Mehta RH, Harjai KJ, Boura J, et al. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction [ J ]. Am J Cardiol, 2003,92 ( 12 ) : 1445-1447.
  • 10Demir I, Yilmaz H, Ermis C, et al. Treatment of no-reflow phenomenon with verapamil after primary stent deployment during myocardial infarction[J]. Jpn Heart J,2002,43(6):573-580.

共引文献5015

同被引文献23

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部